The immunopharmacologic potential of Semaxanib and new generation directed therapeutic drugs: Receptor tyrosine kinase regulation with anti-tumorigenensis/angiogenesis properties.
about
The immunopharmacologic potential of Semaxanib and new generation directed therapeutic drugs: Receptor tyrosine kinase regulation with anti-tumorigenensis/angiogenesis properties.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The immunopharmacologic potent ...... ensis/angiogenesis properties.
@en
The immunopharmacologic potent ...... ensis/angiogenesis properties.
@nl
type
label
The immunopharmacologic potent ...... ensis/angiogenesis properties.
@en
The immunopharmacologic potent ...... ensis/angiogenesis properties.
@nl
prefLabel
The immunopharmacologic potent ...... ensis/angiogenesis properties.
@en
The immunopharmacologic potent ...... ensis/angiogenesis properties.
@nl
P2860
P1476
The immunopharmacologic potent ...... ensis/angiogenesis properties.
@en
P2093
John J Haddad
P2860
P304
P356
10.1016/J.JSPS.2011.09.002
P577
2011-09-23T00:00:00Z